BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34274737)

  • 1. Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?
    Ahmad H; van der Mei I; Taylor B; Zhao T; Xia Q; Palmer AJ
    Mult Scler Relat Disord; 2021 Sep; 54():103138. PubMed ID: 34274737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
    Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument.
    Ahmad H; van der Mei I; Taylor BV; Campbell JA; Palmer AJ
    Mult Scler Relat Disord; 2020 Sep; 44():102358. PubMed ID: 32650122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.
    Campbell JA; Ahmad H; Chen G; van der Mei I; Taylor BV; Claflin S; Henson GJ; Simpson-Yap S; Laslett LL; Hawkes K; Hurst C; Waugh H; Palmer AJ
    Qual Life Res; 2023 Feb; 32(2):553-568. PubMed ID: 36036311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.
    Orji NC; Cox IA; Jason LA; Chen G; Zhao T; Rogerson MJ; Kelly RM; Wills K; Hensher M; Palmer AJ; de Graaff B; Campbell JA
    Qual Life Res; 2024 Jan; 33(1):45-57. PubMed ID: 37561337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.
    Henson GJ; van der Mei I; Taylor BV; Blacklow P; Claflin SB; Palmer AJ; Hurst C; Campbell JA
    Qual Life Res; 2024 Jun; 33(6):1675-1689. PubMed ID: 38578380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument.
    Zheng Q; Cox IA; de Graaff B; Campbell JA; Corte TJ; Glaspole I; Navaratnam V; Hopkins P; Zappala C; Ahmad H; Zhao T; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2023 Jun; 32(6):1609-1619. PubMed ID: 36572788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher diet quality is associated with short and long-term benefits on SF-6D health state utilities: a 5-year cohort study in an international sample of people with multiple sclerosis.
    Kirkland H; Campbell J; Reece J; Nag N; Probst Y; Neate S; De Livera A; Jelinek G; Simpson-Yap S
    Qual Life Res; 2023 Jul; 32(7):1883-1896. PubMed ID: 36821020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype.
    Zhang Y; Taylor BV; Simpson S; Blizzard L; Campbell JA; Palmer AJ; van der Mei I
    Mult Scler; 2021 Jul; 27(8):1262-1275. PubMed ID: 32924841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis.
    Campbell JA; Jelinek GA; Weiland TJ; Nag N; Neate SL; Palmer AJ; Mulhern B; De Livera A; Simpson-Yap S
    Qual Life Res; 2020 Sep; 29(9):2509-2527. PubMed ID: 32488685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities.
    Ul Husnain MI; Hajizadeh M; Ahmad H; Khanam R
    Appl Health Econ Health Policy; 2024 Jul; 22(4):583-598. PubMed ID: 38530626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery.
    Campbell JA; Hensher M; Neil A; Venn A; Otahal P; Wilkinson S; Palmer AJ
    Pharmacoecon Open; 2018 Dec; 2(4):443-458. PubMed ID: 29623636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring health state utility values of parents of children with a serious illness.
    Majmudar IK; Engel L; Muscara F; Stevenson C; McCarthy M; Anderson V; Mihalopoulos C
    Qual Life Res; 2020 Jul; 29(7):1947-1959. PubMed ID: 32335816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
    Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; Ahmad H; Hussain MA; van der Mei I
    J Neurol; 2021 Feb; 268(2):569-581. PubMed ID: 32880072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process.
    Zhang Y; Taylor BV; Simpson S; Blizzard L; van der Mei I
    Eur J Neurol; 2019 Jan; 26(1):155-161. PubMed ID: 30133059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional and temporal differences in health-related quality of life of people with and without osteoarthritis: a 10-year prospective study.
    Zhao T; Ahmad H; Winzenberg T; Aitken D; Graaff B; Jones G; Palmer AJ
    Rheumatology (Oxford); 2021 Jul; 60(7):3352-3359. PubMed ID: 33452525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
    Goodwin E; Green C; Hawton A
    Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Zhao T; Palmer AJ
    Mult Scler Relat Disord; 2020 Sep; 44():102247. PubMed ID: 32554286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
    Goodwin E; Green C; Spencer A
    Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.